PHENOTYPIC CHARACTERIZATION AND INTRACELLULAR CYTOKINES OF MEMORY T-CELLS IN MULTIPLE SCLEROSIS PATIENTS AFTER T-CELL VACCINATION
Abstract
Multiple sclerosis (RS) patients were treated with a vaccine consisted of autological mielin-reactive T-cells. Effector memory CD8+ CD45RO+CD62L- T-cells as well as central memory CD4+ CD45RO+CD62L+ and CD8+ CD45RO+CD62L+ T-cells were significantly increased in MS patients as compared with levels in healthy individuals. T-cells vaccination had no effect on the T-cells memory subpopulation composition. However, vaccine-treated RS patients had significant (by 2 fold) reduction of relative quantity of CD4+IFNγ+IL-4— and CD8+IFNγ+IL-4— memory T-cells, as well as suppression by 6 fold of CD4+ memory cells number, which produce both kinds of cytokines.
About the Authors
I. P. Ivanova
Institute of Clinical Immunology SB RAMS
Russian Federation
Russian Federation
I. V. Savkin
Institute of Clinical Immunology SB RAMS
Russian Federation
Russian Federation
G. V. Seledtsova
Institute of Clinical Immunology SB RAMS
Russian Federation
Russian Federation
A. A. Shishkov
Institute of Clinical Immunology SB RAMS
Russian Federation
Russian Federation
V. I. Seledtsov
Innovation Center of Immanuel Kant Baltic Federal University
Russian Federation
Russian Federation
References
1. Иванова И.П., Селедцов В.И., Банул Н.В., Самарин Д.М. и др. Получение Т-клеточной вак цины и ее применение для лечения рассеянного склероза // Мед. иммунология. - 2005. - Т. 7, № 1. - С. 27-32.
2. Селедцов В.И., Литвинова Л.С., Гончаров А.Г., Шуплецова В.В. и др. Клеточные механизмы генерации иммунологической памяти // Цитокины и воспаление. - 2010. - Т. 9, № 4. - С. 9-15.
3. Селедцов Д.В., Селедцов В.И., Иванова И.П., Литвинова Л.С. Антиген-специфическая иммунотерапия рассеянного склероза // Цитокины и воспаление. - 2010. - Т. 9, № 1. - С. 3-12.
4. Bourdette D.N., Edmonds E., Smith C., Bowen J.D. et al. A highly immunogenic trivalent T cell receptor peptide vaccine for multiple sclerosis // Multiple Sclerosis. - 2005. - Vol. 11, N 5. - Р. 552-561.
5. Burns J., Bartholomew B., Lobo S. Isolation of myelin basic protein-specific T cells predominantly from the memory T-cell compartment in multiple sclerosis // Ann Neurol. - 1999. - Vol. 45. -P. 33-39.
6. Correale J., Farez M., Gilmore W. Vaccines for Multiple sclerosis. CNS Drugs. - 2008. - Vol. 22, N 3. - Р. 175-198.
7. Hellings N., Raus J., Stinissen P. T-cell vaccination in multiple sclerosis: update on clinical application and mode of action // Autoimm. Rev. - 2004. -Vol. 3. - P. 267-275.
8. Liu G.Z., Fang L.B., Hjelmström P., Gao X.G. Increased CD8+ central memory T-cells in patients with multiple sclerosis // Mult. Scler. - 2007. - Vol. 13, N 2. - P. 149-155.
9. Okuda Y., Okuda M., Apatoff B.R., Posnett D.N. The activation memory CD4+ T cells and CD8+ T cells in patients with multiple sclerosis // J. Neurrol. Sci. - 2005. - Vol. 235, N 1-2. - P. 11-17.
10. Vandenbark A.A., Morgan E., Bartholomew R., autoimmune diseases // Neurochem Res. - 2001. - Bourdette D. et al. TCR peptide therapy in human Vol. 26. - P. 713-730.
Review
For citations:
Ivanova I.P., Savkin I.V., Seledtsova G.V., Shishkov A.A., Seledtsov V.I. PHENOTYPIC CHARACTERIZATION AND INTRACELLULAR CYTOKINES OF MEMORY T-CELLS IN MULTIPLE SCLEROSIS PATIENTS AFTER T-CELL VACCINATION. Acta Biomedica Scientifica. 2012;(3(2)):79-82. (In Russ.)
Views:
403
Email this article 
